Real-time Estimate
Cboe BZX
09:58:15 2024-04-29 am EDT
|
5-day change
|
1st Jan Change
|
8.685
USD
|
+2.18%
|
|
+2.41%
|
-29.52%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
3,177
|
2,536
|
3,326
|
2,167
|
1,726
|
1,172
|
-
|
Enterprise Value (EV)
1 |
7,650
|
6,665
|
8,236
|
7,315
|
6,710
|
7,976
|
1,172
|
P/E ratio
|
14.1
x
|
27.1
x
|
10.7
x
|
33.5
x
|
-5.03
x
|
-3.35
x
|
-7.46
x
|
Yield
|
3.81%
|
4.92%
|
3.77%
|
6.1%
|
7.75%
|
11.3%
|
11.3%
|
Capitalization / Revenue
|
5,575,945
x
|
5,623,292
x
|
7,332,689
x
|
4,013,794
x
|
-
|
-
|
-
|
EV / Revenue
|
13,427,445
x
|
14,781,421
x
|
18,157,424
x
|
13,546,572
x
|
-
|
-
|
-
|
EV / EBITDA
|
10.5
x
|
11
x
|
8.88
x
|
12.4
x
|
35.4
x
|
50.6
x
|
3.4
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
2.29
x
|
1.52
x
|
1.85
x
|
1.1
x
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
142,449
|
141,730
|
139,284
|
137,791
|
139,391
|
137,915
|
-
|
Reference price
2 |
22.30
|
17.89
|
23.88
|
15.73
|
12.38
|
8.500
|
8.500
|
Announcement Date
|
2/26/20
|
2/24/21
|
2/23/22
|
2/21/23
|
2/21/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
|
569.7
|
450.9
|
453.6
|
540
|
-
|
-
|
-
|
EBITDA
1 |
728.1
|
608
|
927.9
|
591.5
|
189.8
|
157.8
|
344.8
|
EBIT
1 |
149.6
|
21
|
293
|
191.6
|
-198.5
|
21.36
|
222.1
|
Operating Margin
|
26.26%
|
4.66%
|
64.59%
|
35.48%
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
362.5
|
151.4
|
462.6
|
138.1
|
-336.7
|
-129.2
|
-120.8
|
Net income
|
224.1
|
92.9
|
313.2
|
64.8
|
-
|
-
|
-
|
Net margin
|
39.34%
|
20.6%
|
69.05%
|
12%
|
-
|
-
|
-
|
EPS
2 |
1.580
|
0.6600
|
2.240
|
0.4700
|
-2.460
|
-2.540
|
-1.140
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.8500
|
0.8800
|
0.9000
|
0.9600
|
0.9600
|
0.9600
|
0.9600
|
Announcement Date
|
2/26/20
|
2/24/21
|
2/23/22
|
2/21/23
|
2/21/24
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
|
114.4
|
131.4
|
124.7
|
136.1
|
139.6
|
139.6
|
132.2
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
1 |
202.7
|
187.4
|
160.1
|
118.4
|
165.9
|
147.1
|
90.9
|
195.1
|
33.2
|
-129.4
|
28.85
|
31.97
|
49.62
|
47.33
|
EBIT
1 |
-10.1
|
136
|
91
|
38.3
|
22.2
|
40.1
|
13.4
|
155.4
|
-53.2
|
-173.2
|
-7.072
|
-2.781
|
16.11
|
15.1
|
Operating Margin
|
-8.83%
|
103.5%
|
72.98%
|
28.14%
|
15.9%
|
28.72%
|
10.14%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
103.1
|
72.3
|
48.2
|
-0.5
|
37.5
|
52.9
|
-32.6
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
65.9
|
37.5
|
34.8
|
-9
|
16.4
|
22.6
|
-40.8
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
57.6%
|
28.54%
|
27.91%
|
-6.61%
|
11.75%
|
16.19%
|
-30.86%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
0.4700
|
0.2700
|
0.2400
|
-0.0700
|
0.1200
|
0.1600
|
-0.3000
|
0.2800
|
-0.6600
|
-1.780
|
-0.7200
|
-0.6900
|
-0.5600
|
-0.5600
|
Dividend per Share
|
0.2200
|
0.2400
|
0.2400
|
0.2400
|
0.2400
|
0.2400
|
0.2400
|
-
|
0.2400
|
0.2400
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/3/21
|
2/23/22
|
5/4/22
|
8/3/22
|
11/2/22
|
2/21/23
|
5/3/23
|
8/2/23
|
11/1/23
|
2/21/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
4,473
|
4,129
|
4,910
|
5,148
|
4,984
|
6,803
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
6.143
x
|
6.792
x
|
5.292
x
|
8.703
x
|
26.26
x
|
43.12
x
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
15.3%
|
5.59%
|
18.3%
|
14.2%
|
-8.14%
|
-
|
-
|
ROA (Net income/ Total Assets)
|
3.05%
|
1.27%
|
4.12%
|
-
|
-
|
-
|
-
|
Assets
|
7,343
|
7,317
|
7,603
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
9.720
|
11.80
|
12.90
|
14.30
|
-
|
-
|
-
|
Cash Flow per Share
2 |
-0.1400
|
-0.0900
|
-0.2200
|
0.2400
|
-
|
-1.340
|
-0.0400
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/26/20
|
2/24/21
|
2/23/22
|
2/21/23
|
2/21/24
|
-
|
-
|
Mean consensus UNDERPERFORM Average target price
10.1
USD Spread / Average Target +18.82% Consensus |